Matches in Wikidata for { <http://www.wikidata.org/entity/Q106967339> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q106967339 description "clinical trial" @default.
- Q106967339 description "ensayo clínico" @default.
- Q106967339 description "ensayu clínicu" @default.
- Q106967339 description "klinisch onderzoek" @default.
- Q106967339 description "клінічне випробування" @default.
- Q106967339 description "կլինիկական փորձարկում" @default.
- Q106967339 description "临床试验" @default.
- Q106967339 name "A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects" @default.
- Q106967339 name "A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects" @default.
- Q106967339 type Item @default.
- Q106967339 label "A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects" @default.
- Q106967339 label "A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects" @default.
- Q106967339 prefLabel "A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects" @default.
- Q106967339 prefLabel "A Safety and Pharmacokinetic Study Between HLX02 and Herceptin®(US-licensed and EU-approved) in Healthy Chinese Male Subjects" @default.
- Q106967339 P1132 Q106967339-986C9A24-F637-4E97-89AB-B2C21DE2F3EF @default.
- Q106967339 P1476 Q106967339-887CC608-B084-41BD-8CDC-1402F7CEC0AD @default.
- Q106967339 P2899 Q106967339-39D9F307-0D60-4268-A656-B5ED121BE0A7 @default.
- Q106967339 P3098 Q106967339-51B09676-8433-4477-8114-ED4D08811CB5 @default.
- Q106967339 P31 Q106967339-52548929-5113-4A2D-BF83-6E4B2814698F @default.
- Q106967339 P4135 Q106967339-3F2AB0F8-5BCB-4CD0-858B-4BE30EC8A9F3 @default.
- Q106967339 P4844 Q106967339-F61741E4-E655-4519-8104-24A9BF568B28 @default.
- Q106967339 P580 Q106967339-2E342773-D789-46BC-B44C-4C86240D7419 @default.
- Q106967339 P582 Q106967339-7161322B-BED8-4B8F-84A2-4E7F0FBBC6C8 @default.
- Q106967339 P6099 Q106967339-85C4FEC6-7293-4778-840B-804E111BC301 @default.
- Q106967339 P6153 Q106967339-36DB2EF6-01B4-4493-A220-DA1BFBFABF3B @default.
- Q106967339 P8005 Q106967339-1764C7D1-1EE3-4B43-BEC4-51FB164C2387 @default.
- Q106967339 P8363 Q106967339-A8B413A2-3533-40FA-89DE-01B1A762584E @default.
- Q106967339 P1132 "+111" @default.
- Q106967339 P1476 "A Phase I Study to Compare the Pharmacokinetics, Safety, Tolerability, and Immunogenicity Between HLX02 and Herceptin® (US-licensed and EU-approved Reference Products, Double-blind, Randomized, Parallel-group Part) in Healthy Chinese Male Subjects" @default.
- Q106967339 P2899 "+18" @default.
- Q106967339 P3098 "NCT04670796" @default.
- Q106967339 P31 Q30612 @default.
- Q106967339 P4135 "+45" @default.
- Q106967339 P4844 Q412616 @default.
- Q106967339 P580 "2021-03-02T00:00:00Z" @default.
- Q106967339 P582 "2021-06-01T00:00:00Z" @default.
- Q106967339 P6099 Q5452194 @default.
- Q106967339 P6153 Q1639978 @default.
- Q106967339 P8005 Q76649708 @default.
- Q106967339 P8363 Q78089383 @default.